ALNOV:EPA
Novacyt
€ 0,44
arrow_upward
+1,38%(+0,0060) 1D
18 nov, 17:35:20 GMT+1 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ALNOV genereren…
Openen
€ 0,44
Hoog
€ 0,44
Laag
€ 0,43
Beursw.
32,30 mln.
Gem. vol.
139,48K
Volume
150,99K
52 wk hoog
€ 1,04
52 wk laag
€ 0,29
WPA
€ -0,38
Uitstaande aandelen
72,59 mln.
Aantal medewerkers
228
Openen
€ 0,44
Hoog
€ 0,44
Laag
€ 0,43
Beursw.
32,30 mln.
Gem. vol.
139,48K
Volume
150,99K
52 wk hoog
€ 1,04
52 wk laag
€ 0,29
WPA
€ -0,38
Uitstaande aandelen
72,59 mln.
Aantal medewerkers
228
Nieuwsartikelen
Van webbronnen en nieuwspartners
ChartMill
·
1 uur geleden
S&P 500 Unusual Volume Movers: Nov. 18, 2026
The Motley Fool
·
1 uur geleden
If You'd Invested $1,000 in an S&P 500 ETF Ahead of the Dot-Com Bubble, Here's What You'd Have Today
ChartMill
·
1 uur geleden
S&P 500 Top Movers: Gainers and Losers in the Nov. 18, 2026 US Session
StoneX
·
7 uur geleden
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profiel
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Over Novacyt
CEODavid Allmond
Medewerkers228
Opgericht3 jul 2006
Hoofdkantoor-
SectorHealth Care
Industrie-
Websitenovacyt.com